Grifols have taken a 10 year lease on 14,000 sq. ft, at the park’s latest mid-tech phase, Enterprise. Grifols is a global healthcare company and an industry leader in producing plasma-derived medicines and transfusion medicine. Grifols join the likes of Oval Medical Technology, Horizon Discovery and Stemcell Technologies who are also part of the growing pharma and R&D hub at Cambridge Research Park.
XLB Property asset manage on behalf of Royal London Asset Management. Cambridge Research Park is a thriving business community providing office, laboratory, hi-tech, industrial accommodation and amenity across acres of landscaped grounds. The Park also forms part of Cambridge Compass Enterprise Zone, providing excellent government support for growth and development of businesses. For more information, visit the park’s website at https://lnkd.in/dxN9__q
The appointed leasing agents for the transaction were: Rupert Dando MRICS – Michael Jones – Patrick Stanton